IL-16 represses HIV-1 promoter activity.

J W Maciaszek,N A Parada,W W Cruikshank,D M Center,H Kornfeld,G A Viglianti
DOI: https://doi.org/10.4049/jimmunol.158.1.5
1997-01-01
The Journal of Immunology
Abstract:Abstract IL-16 is produced by CD8+ lymphocytes and has been reported to inhibit HIV-1 and SIV replication in infected PBMCs. CD4 serves as a receptor for the secreted form of IL-16, and IL-16 binding to CD4 induces signal transduction, which affects the activation state of the cell. We hypothesized, therefore, that the effect of IL-16 on HIV-1 replication might occur at the level of virus expression. In transient transfection studies with HIV-1 LTR-reporter gene constructs we found that pretreatment of CD4+ lymphoid cells with recombinant IL-16 repressed HIV-1 promoter activity up to 60-fold, preventing both PMA and Tat activation. This effect of IL-16 required sequences contained within the core enhancer, but was not simply due to the down-regulation of transcription factors binding to this element.
immunology
What problem does this paper attempt to address?